June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Comparison of Gene Expression Profiling and Chromosome 3 Analysis by Fluorescent In Situ Hybridization in Fine Needle Aspiration Biopsy Specimens of Uveal Melanoma
Author Affiliations & Notes
  • Elizabeth Richter
    Retina, Jules Stein Eye Institute, Los Angeles, CA
  • Sujit Itty
    Retina, Jules Stein Eye Institute, Los Angeles, CA
  • Tara A McCannel
    Retina, Jules Stein Eye Institute, Los Angeles, CA
  • Footnotes
    Commercial Relationships Elizabeth Richter, None; Sujit Itty, None; Tara McCannel, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5329. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elizabeth Richter, Sujit Itty, Tara A McCannel; Comparison of Gene Expression Profiling and Chromosome 3 Analysis by Fluorescent In Situ Hybridization in Fine Needle Aspiration Biopsy Specimens of Uveal Melanoma. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5329.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To assess the concordance between results of DecisionDx-UM uveal melanoma specific Gene Expression Profiling (GEP) (Castle Biosciences, Phoenix, AZ) and Fluorescent in Situ Hybridization (FISH) for chromosome 3 analysis in uveal melanomas undergoing intraoperative fine needle aspiration biopsy (FNAB) for metastatic prognostication during brachytherapy.

 
Methods
 

Consecutive patients diagnosed with uveal melanoma who underwent intraoperative transscleral or transvitreal fine needle aspiration biopsy with 30-gauge needle prior to placement of iodine-125 radioactive plaque between November 2012 and January 2014, were retrospectively reviewed. Patient demographics and tumor characteristics were obtained. The results of biopsy specimens, analyzed by cytopathology, FISH for monosomy 3 and 6p gain, and for GEP analysis with the DecisionDx-UM assay, were reviewed.

 
Results
 

A total of 99 intraocular tumors underwent brachytherapy with intraoperative biopsy, including 90 choroidal melanomas, 6 iris melanomas, and 3 uveal metastatic lesions. FISH and GEP results were both available in 44 (44%) patients all with iris or choroidal melanoma. Of these 44, FISH and GEP results were discordant in 7 tumors (15.9%). Six tumors were classified as “Class 1” (four 1A, two 1B), or low risk-for metastasis designation, by GEP but monosomy 3 by FISH; and one tumor was found to be “Class 2” by GEP and disomy 3 by FISH analysis. There was no significant difference with regard to tumor height (p=0.94), patient age (p=0.95), or ciliary body involvement (p=0.97) between discordant and concordant cases. No patients with discordant tumors had confirmed metastatic disease with limited follow up (mean 8.4 months, range 1- 15.5 months).

 
Conclusions
 

Discordance between GEP and Chromosome 3 status by FISH occurred in our series at a rate of 15.9%, which is similar to previously published reports. No patient or tumor characteristics were identified as risk factors for discordance. The metastatic prognosis of uveal melanoma patients with discordant results is unclear from our study due to limited follow up.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×